Steven Lim

Array ( [id] => 7719845 [patent_doc_number] => 20120009180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'ANTI-ABETA OLIGOMER HUMANIZED ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/852581 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24275 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009180.pdf [firstpage_image] =>[orig_patent_app_number] => 12852581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8559904 [patent_doc_number] => 08333967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Anti-Aβ oligomer humanized antibody' [patent_app_type] => utility [patent_app_number] => 12/852548 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36980 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984507 [patent_doc_number] => 20110097319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/851233 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28080 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097319.pdf [firstpage_image] =>[orig_patent_app_number] => 12851233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251870 [patent_doc_number] => 20120156193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/389228 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28329 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156193.pdf [firstpage_image] =>[orig_patent_app_number] => 13389228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440650 [patent_doc_number] => 20100279433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'ASSAY METHOD FOR ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/834271 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9447 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279433.pdf [firstpage_image] =>[orig_patent_app_number] => 12834271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928902 [patent_doc_number] => 20110038861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Methods of Treating Alzheimer\'s Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions Thereof' [patent_app_type] => utility [patent_app_number] => 12/827844 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27676 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038861.pdf [firstpage_image] =>[orig_patent_app_number] => 12827844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638056 [patent_doc_number] => 20130029859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'BIOMARKER ASSAY OF NEUROLOGICAL CONDITION' [patent_app_type] => utility [patent_app_number] => 13/379164 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 17178 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616271 [patent_doc_number] => 20100323970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'SAP VARIANTS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/817535 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19698 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323970.pdf [firstpage_image] =>[orig_patent_app_number] => 12817535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134432 [patent_doc_number] => 20110008334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'NOGO-A BINDING WITH ENHANCED AFFINITY AND PHARMACEUTICAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/816964 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14189 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008334.pdf [firstpage_image] =>[orig_patent_app_number] => 12816964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237016 [patent_doc_number] => 20100267816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HUMAN ANTI-AMYLOID BETA PEPTIDE ANTIBODY AND FRAGMENT OF SAID ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/792064 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11799 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267816.pdf [firstpage_image] =>[orig_patent_app_number] => 12792064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8548774 [patent_doc_number] => 08323654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules' [patent_app_type] => utility [patent_app_number] => 12/788116 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 20 [patent_no_of_words] => 22309 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6126708 [patent_doc_number] => 20110086421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'USE OF BIOLOGICAL PHOTORECEPTORS AS DIRECTLY LIGHT-ACTIVATED ION CHANNELS' [patent_app_type] => utility [patent_app_number] => 12/781962 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6772 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086421.pdf [firstpage_image] =>[orig_patent_app_number] => 12781962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250520 [patent_doc_number] => 08614299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide' [patent_app_type] => utility [patent_app_number] => 13/319710 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6226 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981564 [patent_doc_number] => 08512677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Pyro-glutamate Aβ targeting agents' [patent_app_type] => utility [patent_app_number] => 13/266545 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16300 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518557 [patent_doc_number] => 20100203017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Cladribine Regimen for Treating Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 12/766173 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8425 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203017.pdf [firstpage_image] =>[orig_patent_app_number] => 12766173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237446 [patent_doc_number] => 20100267935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ANTIBODY HAVING INHIBITORY EFFECT ON AMYLOID FIBRIL FORMATION' [patent_app_type] => utility [patent_app_number] => 12/765003 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25379 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267935.pdf [firstpage_image] =>[orig_patent_app_number] => 12765003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504600 [patent_doc_number] => 20100260783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Antibody Specific Binding to A Beta Oligomer and the Use' [patent_app_type] => utility [patent_app_number] => 12/762878 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24516 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260783.pdf [firstpage_image] =>[orig_patent_app_number] => 12762878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767863 [patent_doc_number] => 20120035112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'NEURONAL DIFFERENTIATION-INDUCING PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/258788 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11447 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035112.pdf [firstpage_image] =>[orig_patent_app_number] => 13258788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446245 [patent_doc_number] => 20100279942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'METHODS FOR TREATING MOTOR NEURON DISEASE' [patent_app_type] => utility [patent_app_number] => 12/755809 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8138 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279942.pdf [firstpage_image] =>[orig_patent_app_number] => 12755809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212360 [patent_doc_number] => 20110135660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/729902 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23643 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135660.pdf [firstpage_image] =>[orig_patent_app_number] => 12729902 [rel_patent_id] =>[rel_patent_doc_number] =>)